CLOV vs EXAS
Clover Health Investments Corp (CLOV) versus EXACT Sciences Corporation (EXAS) — a side-by-side from cached financials, not a winner call.
Clover Health Investments Corp (CLOV) is a healthcare plans company listed on US.
EXACT Sciences Corporation (EXAS) is a diagnostics & research company listed on NASDAQ.
Latest reported CLOV revenue for 2024-12-31 was $1.37B. Net income was -$43.0M. Revenue was up 8.8% from 2023-12-31 to 2024-12-31. CLOV currently screens at market cap $1.55B.
Latest reported EXAS revenue for 2024-12-31 was $2.76B. Net income was -$1.03B. Revenue was up 10.4% from 2023-12-31 to 2024-12-31. EXAS currently screens at market cap $20.03B.
CLOV currently screens at market cap $1.55B. EXAS currently screens at market cap $20.03B.
Not investment advice. Open the CLOV and EXAS stock pages for the full models.
Not investment advice.